Abstract
Nonsteroidal anti-inflammatory drugs are widely used for systemic control of acute or chronic pain and inflammation. Topical ophthalmic NSAIDs are used to treat ocular surface and anterior segment inflammation as well as postoperative management of pain and inflammation. Bromfenac ophthalmic solution 0.09% is rapidly becoming a widely prescribed topical ophthalmic within its class. Bromfenac has an extensive global safety record as an anti-inflammatory drug, as well as in the management of ocular pain and inflammation following cataract and refractive surgery and corneal abrasions. Bromfenac’s unique chemical structure makes it both a potent anti-inflammatory drug and a lipophilic molecule that penetrates ocular tissues, ensuring sustained drug levels in all ocular tissues for over 24 h.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
